SAPHNELO
Concentrate for solution for infusion, 300mg
RxActive license
Active substance (INN)
anifrolumab
Pharmaceutical form
Pharmaceutical formConcentrate for solution for infusion
Strength300mg
PackagingUkupno 1 bočica staklena sa 2ml koncentrata za rastvor za infuziju u kartonskoj kutiji
ManufacturerAstraZeneca AB, Sweden
Therapeutic groupAntineoplastic and immunomodulating agents (L04AG11)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateNovember 28, 2023
Source: CInMED register